Accord Healthcare

SEP 2, 2026 · SAFETY RECALL

Class II recall: Levothyroxine Sodium Tablets, USP, 137 mcg (0.137 mg), packaged in a) 90-count bottles (NDC 16729-454-15) b) 1000-count bottles (NDC 16729-454-17), Rx Only, Man

U.S. Food and Drug Administration

FDA Class II recall of levothyroxine sodium tablets for subpotent drug distribution; a safety action requiring immediate attention but not a clinical trial.

SEP 2, 2026 · SAFETY RECALL

Class II recall: Levothyroxine Sodium Tablets, USP, 75 mcg (0.075 mg), 1000-count bottles, Rx Only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by

U.S. Food and Drug Administration

FDA Class II recall of levothyroxine sodium tablets for subpotency; affects patients nationwide and requires immediate clinical attention to dosing adequacy.

SEP 2, 2026 · SAFETY RECALL

Class II recall: Levothyroxine Sodium Tablets, USP, 125 mcg (0.125 mg), 1000-count bottles, Rx Only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured b

U.S. Food and Drug Administration

FDA Class II recall of levothyroxine sodium tablets for subpotent drug distribution; affects patients nationwide who may receive ineffective thyroid replacement therapy.

SEP 2, 2026 · SAFETY RECALL

Class II recall: Levothyroxine Sodium Tablets, USP, 175 mcg (0.175 mg), packaged in a) 90-count bottles (NDC 16729-456-15), and b) 1000-count bottles (NDC 16729-456-17), Rx Only

U.S. Food and Drug Administration

FDA Class II recall of levothyroxine sodium tablets due to subpotency, affecting drug distribution nationwide and requiring clinical awareness of affected batches.

SEP 2, 2026 · SAFETY RECALL

Class II recall: Levothyroxine Sodium Tablets, USP, 50 mcg (0.05 mg), 1000-count bottles, Rx Only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by:

U.S. Food and Drug Administration

FDA Class II recall of levothyroxine sodium tablets for subpotency; a safety action affecting drug quality and patient safety nationwide.

SEP 2, 2026 · SAFETY RECALL

Class II recall: Levothyroxine Sodium Tablets, USP, 200 mcg (0.2 mg), packaged in a) 90-count bottles (NDC 16729-457-15) and b) 1000-count bottles (NDC 16729-457-17), Rx Only, M

U.S. Food and Drug Administration

FDA Class II recall of levothyroxine sodium tablets for subpotency; affects product safety and efficacy in patients nationwide.

SEP 2, 2026 · SAFETY RECALL

Class II recall: Levothyroxine Sodium Tablets, USP, 100 mcg (0.1 mg), packaged in a) 90-count bottles (NDC 16729-451-15) and b) 1000-count bottles, (NDC 16729-451-17), Rx Only,

U.S. Food and Drug Administration

FDA Class II recall of levothyroxine sodium tablets for subpotency; affects patients nationwide and requires immediate awareness of affected lot numbers.

SEP 2, 2026 · SAFETY RECALL

Class II recall: Levothyroxine Sodium Tablets, USP, 88 mcg (0.088 mg), 1000-count bottles, Rx Only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by

U.S. Food and Drug Administration

FDA Class II recall of levothyroxine sodium tablets for subpotent drug distribution affecting nationwide U.S. supply; requires immediate clinician awareness of potential product failure.